Glucose and insulin effects on the novo amino acid synthesis in young men: studies with stable isotope labeled alanine, glycine, leucine, and lysine.
We have explored interrelationships between te dynamic aspects of whole body glucose and alanine and glycine metabolism in adult humans. Using a primed, continuous intravenous infusion of [1-13C] leucine or lysine given simultaneously with [2H3] or [15N]alanine or [15N]glycine, respectively, whole body alanine and glycine fluxes and their rates of de novo synthesis were determined in three experiments with healthy young men. Subjects were studied in the post-absorptive state and during a 150 min period of an intravenous infusion with unlabeled glucose, at a rate of 4 mg.kg-1 min-1. In one experiment, insulin was given together with the glucose infusion to maintain normoglycemia. In the other two studies, subjects received glucose alone. For the post-absorptive state, alanine flux (mean +/- SEM) was 381 +/- 26 and 317 +/- 18 mumole.kg-1 hr-1 in two separate experiments and glycine flux was 240 +/- 22 mumole.kg-1 hr-1. De novo synthesis of alanine and glycine accounted for 75%-81% and 81% of flux, respectively. Infusion with glucose alone raised plasma glucose to a mean level of 152 mg/dl and increased alanine flux, due to a rise in alanine synthesis of 98 mumole.kg-1 hr-1 (p less than 0.01). Glycine flux and synthesis rate were unaffected by the glucose infusion. When insulin was given with glucose to maintain normoglycemia, the rate of alanine synthesis was unchanged. Because glucose uptake rate, measured with [6,6-2H2] glucose was the same whether glucose was infused along or with exogenous insulin, these results support the view that the circulating plasma glucose level itself may affect alanine synthesis and that the hyperglycemic state is an important factor in regulating interorgan nitrogen transfer, via alanine, in various pathophysiologic states.
D000328:Adult; D000409:Alanine / Q000096:biosynthesis; D000596:Amino Acids / Q000096:biosynthesis* / Q000378:metabolism; D001786:Blood Glucose / Q000032:analysis; D005947:Glucose / Q000494:pharmacology*; D005998:Glycine / Q000096:biosynthesis; D006801:Humans; D006943:Hyperglycemia / Q000378:metabolism; D007263:Infusions, Parenteral; D007328:Insulin / Q000494:pharmacology*; D007930:Leucine / Q000378:metabolism; D008239:Lysine / Q000378:metabolism; D008297:Male; D009584:Nitrogen / Q000378:metabolism
D000596:Amino Acids; D001786:Blood Glucose; D007328:Insulin; D007930:Leucine; D005947:Glucose; D008239:Lysine; D009584:Nitrogen; D000409:Alanine; D005998:Glycine